Literature DB >> 33869097

Surviving Extreme Anaemia.

Joana M Esteves1, Joana Fernandes2, Pedro Oliveira Monteiro3, Mariana Almeida4, Luis Nogueira-Silva4,5,6, Jorge Almeida4,6.   

Abstract

Before the development of transfusion medicine, severe anaemia was an important cause of morbidity and mortality. The discovery of haematopoietic mechanisms and essential nutrients made it possible to easily treat and prevent this condition. Nevertheless, it is often fatal in patients presenting with extreme anaemia (haemoglobin levels <2 g/dl). We report the rare case of a 54-year-old woman who presented with profound megaloblastic anaemia (haemoglobin of 1.7 g/dl) due to vitamin B12 deficiency, and was successfully treated. LEARNING POINTS: The discovery of vitamin B12 in the 20th century led to the successful and easy treatment of thousands of patients with anaemia.Focus on patient adherence to treatment and medical advice is essential in order to manage chronic conditions such as post-gastrectomy nutritional deficiencies.Extreme anaemia is very rare and associated with high mortality; treatment should be tailored to acute or chronic anaemia and in cases where haemodynamic stability is guaranteed, a restrictive blood transfusion strategy should be considered to reduce the risk of complications. © EFIM 2021.

Entities:  

Keywords:  Severe anaemia; nutritional deficiency; vitamin B12

Year:  2021        PMID: 33869097      PMCID: PMC8046282          DOI: 10.12890/2021_002357

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  30 in total

1.  Post-transfusion posterior leukoencephalopathy with cytotoxic and vasogenic edema precipitated by vasospasm.

Authors:  Kyoung Heo; Sun Ah Park; Jong Yun Lee; Byung In Lee; Seung-Koo Lee
Journal:  Cerebrovasc Dis       Date:  2003       Impact factor: 2.762

2.  Extreme hemodilution due to massive blood loss in tumor surgery.

Authors:  A Zollinger; P Hager; T Singer; H P Friedl; T Pasch; D R Spahn
Journal:  Anesthesiology       Date:  1997-10       Impact factor: 7.892

Review 3.  Clinical practice. Vitamin B12 deficiency.

Authors:  Sally P Stabler
Journal:  N Engl J Med       Date:  2013-01-10       Impact factor: 91.245

4.  Case report: intraoperative management of extreme hemodilution in a patient with a severed axillary artery.

Authors:  JianQiang Dai; WeiFeng Tu; Zheng Yang; RiHui Lin
Journal:  Anesth Analg       Date:  2010-06-25       Impact factor: 5.108

5.  Posterior reversible encephalopathy syndrome secondary to blood transfusion.

Authors:  Karanbir Singh; Rajesh Gupta; Haris Kamal; Nicholas J Silvestri; Gil I Wolfe
Journal:  J Clin Neurosci       Date:  2014-12-23       Impact factor: 1.961

6.  A Novel Human β-Globin Gene Variant [Hb London-Ontario, HBB: c.332T>G] is Associated with Transfusion-Dependent Anemia in a Patient with a Hemoglobin Electrophoresis Pattern Consistent with β-Thalassemia Trait.

Authors:  Marc N Bienz; Cyrus Hsia; John S Waye; Margo Bode; Ziad Solh
Journal:  Hemoglobin       Date:  2019-06-27       Impact factor: 0.849

7.  Severe ceftriaxone-induced hemolysis complicated by diffuse cerebral ischemia in a child with sickle cell disease.

Authors:  Laura G Schuettpelz; Deanna Behrens; Matthew I Goldsmith; Todd E Druley
Journal:  J Pediatr Hematol Oncol       Date:  2009-11       Impact factor: 1.289

8.  Reversible cerebral vasoconstriction syndrome after blood transfusion.

Authors:  Yi-Hsuan Dou; Jong-Ling Fuh; Shih-Pin Chen; Shuu-Jiun Wang
Journal:  Headache       Date:  2014-03-13       Impact factor: 5.887

Review 9.  The discovery of vitamin B(12).

Authors:  John M Scott; Anne M Molloy
Journal:  Ann Nutr Metab       Date:  2012-11-26       Impact factor: 3.374

10.  Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference.

Authors:  Markus M Mueller; Hans Van Remoortel; Patrick Meybohm; Kari Aranko; Cécile Aubron; Reinhard Burger; Jeffrey L Carson; Klaus Cichutek; Emmy De Buck; Dana Devine; Dean Fergusson; Gilles Folléa; Craig French; Kathrine P Frey; Richard Gammon; Jerrold H Levy; Michael F Murphy; Yves Ozier; Katerina Pavenski; Cynthia So-Osman; Pierre Tiberghien; Jimmy Volmink; Jonathan H Waters; Erica M Wood; Erhard Seifried
Journal:  JAMA       Date:  2019-03-12       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.